Rank #1936FENC

Fennec Pharmaceuticals Inc.

$8.78

-2.12% (Daily)

Market Cap

$299.87M

Revenue

$38.79M

Rank by MCap

#1936

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Jeffrey S. Hackman

Headquarters

Research Triangle Park, NC

Employees

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in Septembe...